1. Nat. Rev. Urol. doi:10.1038/nrurol.2016.26
Figure 1 The structure of prostate-specific membrane antigen (PSMA), its binding sites for PSMA ligands and the most frequently used antibodies
Figure 1 | The structure of prostate-specific membrane antigen (PSMA), its binding sites for PSMA ligands and the most frequently used antibodies. a | The short intracellular domain containing a binding site that can be targeted with 7E11 antibodies. b | The hydrophobic transmembrane region. The extracellular part of PSMA consists of section c | that contains two domains of unknown function and proline-rich and glycine-rich regions as linkers, d | that is the large catalytic domain, which contains a binding site for J591 antibodies as well as the active substrate recognition site that is being targeting by PSMA inhibitors and e | the final domain of unknown function to which a helical dimerization domain is localized.
Maurer, T. et al. (2016) Current use of PSMA–PET in prostate cancer management
Nat. Rev. Urol. doi: /nrurol